327
Views
25
CrossRef citations to date
0
Altmetric
Research Article

IL-2 production by dendritic cells promotes Foxp3+ regulatory T-cell expansion in autoimmune-resistant NOD congenic mice

, &
Pages 406-414 | Received 28 Sep 2010, Accepted 29 Oct 2010, Published online: 19 Jan 2011
 

Abstract

Il2 allelic variation in non-obese diabetic mice imparts marked resistance to type 1 diabetes. IL-2 is pivotal for the fitness and homeostasis of Foxp3+ regulatory T (Treg) cells, and the Idd3B6 locus augments IL-2 production by effector T cells, which in turn enhances the potency of Treg cell functions. Given the important role dendritic cells (DCs) play in Treg cell-mediated tolerance induction, we hypothesized that DCs from Idd3B6 congenic mice contribute to increased Treg cell activity. Here, we observed that CD11c+ DCs, harboring protective Idd3B6 genes, are endowed with the capacity to secrete IL-2, enabling them to preferentially promote Treg cell functions in vitro and in vivo. Our results show that Il2 gene variation may imprint DCs to favor T-cell regulation of autoimmunity.

Acknowledgements

This work was supported from the grants of CIHR (MOP67211) and CDA (#GA-3-05-1898-CP). C.A.P. holds the Canada Research Chair.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.